GSK's shingles vaccine Shingrix sales are well ahead of projections ~ nearly $1billion sales for 2018 - yet no research or studies in autoimmune or immunosuppressed patients! Talk to your GSK rep. https://t.co/kvkOSsmsKy https://t.co/4yCDVe7ksC